Inhibition of VAP-1 by Caffeine in Healthy Human Volunteers Study
NCT02098785
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Local resource issue - never actually started post ethics approval.
Conditions
Liver Disease
Interventions
DRUG:
Caffeine citrate
Sponsor
University of Birmingham